High-Dose Radiotherapy and Risk-Adapted Androgen Deprivation in Localised Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial
Lancet Oncol 2022 Apr 12;[EPub Ahead of Print], A Zapatero, A Guerrero, X Maldonado, A Álvarez, CG San-Segundo, MÁC Rodríguez, JM Solé, AP Olivé, F Casas, A Boladeras, CM de Vidales, MLV de la Torre, S Vara, JL Sanz, FA CalvoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.